Skip to main content

Table 3 Self-reported influenza-like illness symptoms and a COVID-19 diagnosis in patients with rheumatic diseases and household contacts at baseline

From: Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil

Symptoms

All

N = 9589

n (%)

RD Patients

N = 5164

n (%)**

Household co-habitants

N = 4378

n (%) *

Difference

(95% CI)

p*

Any

1822 (19.1)

1135 (22)

687 (15.7)

6.3 (4.7; 7.9)

 < 0.001

Fatigue

531 (5.6)

328 (6.4)

203 (4.6)

1.8 (0.9; 2.7)

 < 0.001

Headache

734 (7.7)

453 (8.8)

281 (6.4)

2.4 (1.3; 3.5)

 < 0.001

Rhinorrhea

976 (10.2)

601 (11.6)

375 (8.6)

3.0 (1.8; 4.2)

 < 0.001

Dysgeusia

242 (2.5)

146 (2.8)

96 (2.2)

0.6 (0; 1.2)

0.049

Shortness of breath

266 (2.8)

188 (3.6)

78 (1.8)

1.8 (1.2; 2.4)

 < 0.001

Sore throat

704 (7.4)

455 (8.8)

249 (5.7)

3.1 (2.1; 4.1)

 < 0.001

Fever

486 (5.1)

276 (5.3)

210 (4.8)

0.5 (− 0.4; 1.4)

0.225

Anosmia

209 (2.2)

120 (2.3)

89 (2)

0.3 (− 0.3; 0.9)

0.333

Cough

910 (9.5)

579 (11.2)

331 (7.6)

3.6 (2.4; 4.8)

 < 0.001

Fever AND Shortness of breath

123 (1.3)

80 (1.9)

43 (1.2)

0.7 (0.2; 1,2)

0.005

Fever AND Cough AND Shortness of breath

83 (0.9)

53 (1.3)

30 (0.8)

0.5 (0.1; 0.9)

0.034

BMH COVID-19 criteria

293 (3.1)

169 (4.03%)

124 (3.25%)

0.78 (− 0.05; 1.60)

0.065

  1. Bold values indicate statistical significance (p < 0.05)
  2. The results are expressed as means, standard deviation and percentages
  3. BMH, Brazilian Ministry of Health
  4. *There are 45 missing data; **There are 2 missing